2022
Borrelia miyamotoi Meningoencephalitis in an Immunocompetent Patient
Gandhi S, Narasimhan S, Workineh A, Mamula M, Yoon J, Krause PJ, Farhadian SF. Borrelia miyamotoi Meningoencephalitis in an Immunocompetent Patient. Open Forum Infectious Diseases 2022, 9: ofac295. PMID: 35873293, PMCID: PMC9301576, DOI: 10.1093/ofid/ofac295.Peer-Reviewed Original Research
2006
The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America
Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB. The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases 2006, 43: 1089-1134. PMID: 17029130, DOI: 10.1086/508667.Peer-Reviewed Original ResearchConceptsInfectious Diseases SocietyHuman granulocytic anaplasmosisDiseases SocietyLyme diseasePost-Lyme disease syndromeGranulocytic anaplasmosisPrevious treatment guidelinesManagement of patientsClinical practice guidelinesEvidence-based guidelinesHealth care providersTickborne infectionTreatment guidelinesClinical manifestationsAntimicrobial therapyClinical assessmentPractice guidelinesCare providersDisease syndromeExpert panelDiseasePreventionPatientsTherapyInfection
1998
Persistent Parasitemia after Acute Babesiosis
Krause P, Spielman A, Telford S, Sikand V, McKay K, Christianson D, Pollack R, Brassard P, Magera J, Ryan R, Persing D. Persistent Parasitemia after Acute Babesiosis. New England Journal Of Medicine 1998, 339: 160-165. PMID: 9664092, DOI: 10.1056/nejm199807163390304.Peer-Reviewed Original ResearchConceptsDuration of parasitemiaSpecific therapySide effectsInfected peopleCommunity-based studyEpisodes of illnessProtozoan Babesia microtiBabesial DNASymptoms of babesiosisRecrudescent diseaseQuinine therapyThin blood smearsPersistent parasitemiaInfected subjectsSerologic testsIll subjectsSpecific symptomsAcute babesiosisMore monthsParasitemiaBlood smearsBabesial infectionTherapyBabesia microtiSymptoms
1989
Enhancement of neutrophil function for treatment of neonatal infections
KRAUSE P, HERSON V, EISENFELD L, JOHNSON G. Enhancement of neutrophil function for treatment of neonatal infections. The Pediatric Infectious Disease Journal 1989, 8: 382-389. PMID: 2664694, DOI: 10.1097/00006454-198906000-00011.Peer-Reviewed Original ResearchConceptsNewborn infantsRisk of morbidityFresh frozen plasmaMaximum therapeutic benefitHost defense mechanismsNeonatal infectionImportant therapyNeutrophil functionFrozen plasmaPMN functionTherapeutic benefitAdult PMNInfectionFurther studiesInfantsNew antibioticsDefense mechanismsTransfusionMorbidityNeonatesTherapyMortalityAdministrationImpairmentAntibodies
1984
Occurrence of Clostridium difficile toxin-associated gastroenteritis following antibiotic therapy for otitis media in young children
HYAMS J, FEDER H, KRAUSE P, FRICK J, MCLAUGHLIN J, FURTH T, HINE P. Occurrence of Clostridium difficile toxin-associated gastroenteritis following antibiotic therapy for otitis media in young children. The Pediatric Infectious Disease Journal 1984, 3: 433-436. PMID: 6333674, DOI: 10.1097/00006454-198409000-00009.Peer-Reviewed Original ResearchConceptsToxin-positive stoolsOtitis mediaAntibiotic therapyAcute otitis mediaPathogenesis of diarrheaIncidence of diarrheaYoung childrenClostridium difficile toxinProspective studyDifficile toxinDiarrheaC. difficileOlder childrenFurther studiesPatientsStoolTherapyChildrenAge sixAge threeOutpatientsPathogenesisYearsGastroenteritisIncidence